Vildagliptin vs sulfonylurea in Indian Muslim diabetes patients fasting during Ramadan.

Autor: Shete A; Abhijit Shete, Medical Department, Novartis Pharma AG, CH-4002 Basel, Switzerland., Shaikh A; Abhijit Shete, Medical Department, Novartis Pharma AG, CH-4002 Basel, Switzerland., Nayeem KJ; Abhijit Shete, Medical Department, Novartis Pharma AG, CH-4002 Basel, Switzerland., Rodrigues L; Abhijit Shete, Medical Department, Novartis Pharma AG, CH-4002 Basel, Switzerland., Ali MS; Abhijit Shete, Medical Department, Novartis Pharma AG, CH-4002 Basel, Switzerland., Shah P; Abhijit Shete, Medical Department, Novartis Pharma AG, CH-4002 Basel, Switzerland., Khanna R; Abhijit Shete, Medical Department, Novartis Pharma AG, CH-4002 Basel, Switzerland., Majid S; Abhijit Shete, Medical Department, Novartis Pharma AG, CH-4002 Basel, Switzerland., Rasheed SA; Abhijit Shete, Medical Department, Novartis Pharma AG, CH-4002 Basel, Switzerland., Shaikh S; Abhijit Shete, Medical Department, Novartis Pharma AG, CH-4002 Basel, Switzerland., Rahman T; Abhijit Shete, Medical Department, Novartis Pharma AG, CH-4002 Basel, Switzerland.

Publikováno v: World journal of diabetes [World J Diabetes] 2013 Dec 15; Vol. 4 (6), pp. 358-64.